NCT05430815

Brief Summary

The purpose of the study is to design, implement, and evaluate a holistic postpartum women's health care system for women who have cardiovascular risk factors for severe maternal morbidity (SMM) including chronic hypertension, chronic diabetes, gestational diabetes, pre-pregnancy obesity, or a hypertensive disorder of pregnancy (HDP) which includes gestational hypertension or preeclampsia. The researchers will use a sequential mixed methods design. First, the researchers will conduct in-depth interviews with women who have given birth in the prior year to characterize barriers and facilitators to accessing postpartum care. The information from these interviews will be used to inform the design of a postpartum care system. Next, the researchers will conduct a pragmatic randomized trial to test the effectiveness of the system on postpartum care engagement versus standard of care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
320

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 20, 2022

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 24, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

August 8, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2024

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 22, 2025

Completed
4 months until next milestone

Results Posted

Study results publicly available

August 22, 2025

Completed
Last Updated

May 14, 2026

Status Verified

April 1, 2026

Enrollment Period

2 years

First QC Date

June 20, 2022

Results QC Date

July 30, 2025

Last Update Submit

April 22, 2026

Conditions

Keywords

Maternal mortalitySevere maternal morbidityPostpartum care

Outcome Measures

Primary Outcomes (1)

  • Number of Participants Attending a Comprehensive Postpartum Visit

    The postpartum visit occurs between 4 and 12 weeks after delivery and is defined as a preventive care visit with an obstetric care provider (e.g., obstetrician-gynecologist, certified nurse midwife, or primary care provider with additional training relevant to postpartum care) that included an assessment of assessing multiple aspects of physical and mental health. Comprehensive postpartum visit attendance was identified using data from medical records using a standardized abstraction form.

    12 weeks after delivery

Secondary Outcomes (20)

  • Number of Participants Attending Any Postpartum Visit

    12 weeks after delivery

  • Number of Participants for Whom Postpartum Diabetes Screening Was Ordered

    12 weeks after delivery

  • Number of Participants for Whom Postpartum Diabetes Screening Was Performed

    12 weeks after delivery

  • Number of Participants With Diabetes for Whom Postpartum Diabetes Screening Was Ordered

    12 weeks after delivery

  • Number of Participants With Diabetes for Whom Postpartum Screening Was Performed

    12 weeks after delivery

  • +15 more secondary outcomes

Study Arms (2)

Enhanced Postpartum Care System

EXPERIMENTAL

Women with a documented diagnosis of chronic diabetes, chronic hypertension, gestational diabetes, hypertensive disorder of pregnancy (gestational hypertension or preeclampsia), or pre-pregnancy obesity who are randomized to receive enhanced postpartum care.

Behavioral: Enhanced Postpartum Care System

Standard of Care

NO INTERVENTION

Women with a documented diagnosis of chronic diabetes, chronic hypertension, gestational diabetes, or hypertensive disorder of pregnancy (gestational hypertension or preeclampsia), or pre-pregnancy obesity who are randomized to receive standard postpartum care.

Interventions

The intervention consists of a comprehensive postpartum care system that integrates American College of Obstetrician and Gynecologist's (ACOG) postpartum care guidelines together with American College of Cardiology and American Heart Association (ACC/AHA) guidelines for the prevention of cardiovascular disease in women, as well as patient preferences for care coordination and communication. The system consists of: 1) a tailored postpartum care plan that is collaboratively developed with patient and provider input and addresses both social and medical needs; 2) an electronic medical record (EMR) based tool for documenting the plan and monitoring postpartum care; and 3) a postpartum follow-up phone call at 1 week postpartum.

Enhanced Postpartum Care System

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • pregnant women between 20-34 weeks of gestation
  • have received 1 or more prenatal care visits at Grady Memorial Hospital in Atlanta, Georgia (GA)
  • intend to deliver at Grady Memorial Hospital
  • speak English or Spanish
  • have a diagnosis of chronic diabetes, chronic hypertension, gestational diabetes, pre-pregnancy obesity (body mass index \[BMI\] of 30 or greater), and/or a hypertensive disorder of pregnancy (gestational hypertension or preeclampsia) documented in the electronic medical record (EMR)

You may not qualify if:

  • adults unable to consent, infants, and prisoners

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Grady Memorial Hospital

Atlanta, Georgia, 30303, United States

Location

Related Publications (1)

  • Stanhope KK, Stallworth T, Forrest AD, Vuncannon D, Juarez G, Boulet SL, Geary F, Dunlop AL, Blake SC, Green VL, Jamieson DJ. Planning for the forgotten fourth trimester of pregnancy: A parallel group randomized control trial to test a postpartum planning intervention vs. standard prenatal care. Contemp Clin Trials. 2024 Aug;143:107586. doi: 10.1016/j.cct.2024.107586. Epub 2024 Jun 3.

MeSH Terms

Conditions

Maternal Death

Condition Hierarchy (Ancestors)

Parental DeathDeathPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Anne Dunlop, MD, MPH
Organization
Emory University

Study Officials

  • Anne Dunlop, MD, MPH

    Emory University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Information on all outpatient visits occurring between delivery discharge and 12 weeks postpartum will be abstracted and blinded for review. Two independent physicians will review the blinded information and determine whether the visit meets the criteria for a comprehensive postpartum visit.
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 20, 2022

First Posted

June 24, 2022

Study Start

August 8, 2022

Primary Completion

July 31, 2024

Study Completion

April 22, 2025

Last Updated

May 14, 2026

Results First Posted

August 22, 2025

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

The final fully deidentified dataset that will be made available for sharing will include sociodemographic, health behavioral, and health care utilization data from both questionnaire and medical record abstraction, to include race/ethnicity, age, insurance type, visits to health care provider/clinic/or hospital within one year postpartum, including any diagnoses, medical testing and/or laboratory screenings (and results of those tests), prescribed medications and adherence to prescribed medications, as well as data related to any subsequently conceived pregnancy.

Shared Documents
STUDY PROTOCOL
Time Frame
Data will become available one year after study completion (starting May 1, 2025) and will be made available for 5 years (through April 30, 2030).
Access Criteria
The researchers will make the data and associated documentation available to users under a data-sharing agreement. Outside researchers must submit a Data Analysis Request Form, which requires elucidation of the specific data requested along with a statement that the investigator must provide: 1) a commitment to using the data only for research purposes and not to identify any individual participant; 2) a commitment to securing the data using appropriate computer technology; and 3) a commitment to destroying or returning the data after analyses are completed. The Data Analysis Request Form will be made web-accessible with directions to submit the request for review. Outside investigators must have satisfactorily completed a Data Use and Confidentiality Agreement, before the anonymized data is released.

Locations